These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26463250)

  • 21. Stopping murder by medicine: introducing the Model Law on Medicine Crime.
    Attaran A
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):127-132. PubMed ID: 25897071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The counterfeit anti-malarial is a crime against humanity: a systematic review of the scientific evidence.
    Karunamoorthi K
    Malar J; 2014 Jun; 13():209. PubMed ID: 24888370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medicines counterfeiting is a complex problem: a review of key challenges across the supply chain.
    Tremblay M
    Curr Drug Saf; 2013 Feb; 8(1):43-55. PubMed ID: 23656447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Front line of combating counterfeit medicines, globally and locally].
    Kimura K
    Yakugaku Zasshi; 2014; 134(2):195-6. PubMed ID: 24492222
    [No Abstract]   [Full Text] [Related]  

  • 25. Update on counterfeit antibiotics worldwide; public health risks.
    Delepierre A; Gayot A; Carpentier A
    Med Mal Infect; 2012 Jun; 42(6):247-55. PubMed ID: 22621827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interventions to combat or prevent drug counterfeiting: a systematic review.
    El-Jardali F; Akl EA; Fadlallah R; Oliver S; Saleh N; El-Bawab L; Rizk R; Farha A; Hamra R
    BMJ Open; 2015 Mar; 5(3):e006290. PubMed ID: 25787989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Counterfeit drugs in Israel and worldwide. Part II: distribution profile and anti-counterfeiting strategies and actions].
    Furman-Assaf S; Tamir O; Marom E; Arieli M; Shemer J
    Harefuah; 2010 Jul; 149(7):470-5, 479. PubMed ID: 21465764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global scenario of counterfeit antimalarials: A potential threat.
    Arora T; Sharma S
    J Vector Borne Dis; 2019; 56(4):288-294. PubMed ID: 33269727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Impact of European e-commerce liberalisation on pharmaceutical crime : The ALPhA research project].
    Sinn A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1245-1254. PubMed ID: 28929171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Operation Pangea - standing together in combat against international pharmaceutical crime].
    Smolka K; Gronwald K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1233-1239. PubMed ID: 28929174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. All the players in the game: driving home the global commitment for legitimate drugs.
    Babyar J
    Drug Dev Ind Pharm; 2018 Nov; 44(11):1868-1870. PubMed ID: 30114946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Legislations combating counterfeit drugs in Hong Kong.
    Lai CW; Chan WK
    Hong Kong Med J; 2013 Aug; 19(4):286-93. PubMed ID: 23687210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health and economic consequences of counterfeit drugs.
    Seiter A
    Clin Pharmacol Ther; 2009 Jun; 85(6):576-8. PubMed ID: 19451909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceutical counterfeiting.
    Deisingh AK
    Analyst; 2005 Mar; 130(3):271-9. PubMed ID: 15724152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The Working Group of Enforcement Officers (WGEO) : The European Network of Drug Regulatory Authorities to Combat Pharmaceutical Crime].
    Wittstock M; Streit R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1228-1232. PubMed ID: 28980025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Criminal Action Against Drug Counterfeiters: Assessment of the FDA Office of Criminal Investigation Database 2016 Through 2021.
    White CM
    Ann Pharmacother; 2022 Dec; 56(12):1333-1338. PubMed ID: 35502467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmaceutical counterfeiting and the RFID technology intervention.
    Coustasse A; Arvidson C; Rutsohn P
    J Hosp Mark Public Relations; 2010 Jul; 20(2):100-15. PubMed ID: 20582850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spurious and counterfeit drugs: a growing industry in the developing world.
    Gautam CS; Utreja A; Singal GL
    Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugs, drugs--who has the drugs?
    Blair J
    J Healthc Prot Manage; 2012; 28(1):28-32. PubMed ID: 22423518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Counterfeit drugs as a gobal threat to health].
    Golocorbin Kon S; Mikov M
    Med Pregl; 2011; 64(5-6):285-90. PubMed ID: 21789919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.